Contribution
My Lords, I am grateful for the debate that we have had on these amendments and the points that have been put forward. I will address the amendments together as well as, indeed, focusing on the Health Bill. I make that point as I am about to turn first to Amendment 279QP tabled by the noble Baroness, Lady Cass, and spoken to by the noble Lord, Lord Singh; and my noble friend Lord Hunt also made reference, as did other noble Lords, to matters relating to the conversion practices Bill. I am grateful to the noble Lord, Lord Scriven, for speaking about his involvement in this matter. Of course, as the noble Lord was referring to, that Bill is subject to pre-legislative scrutiny, to which noble Lords are welcome to contribute and I certainly hope that that they will do.
My noble friend Lord Hunt and the noble Baroness, Lady Barker, spoke in particular to the point that children and young people who are questioning their gender identity deserve compassionate care that takes account of their individual needs and circumstances. That is a duty upon the health service as well as upon all of us.
Your Lordships’ House will know that this Government, working in full partnership with NHS England, are continuing to implement the findings and the recommendations of the review, conducted by the noble Baroness, Lady Cass, of the NHS Children and Young People’s Gender Service, which was commissioned during the term of the previous Government. I am grateful to the noble Baroness, Lady Cass, for both her previous work and her continuing work, as well as for the clarity that she brings to this matter.
I will speak to the noble Baroness’s points about standards for gender services, which are key. Since the review’s publication in 2024, four new regional services are providing holistic care, centered on psychosocial support. They have opened and are seeing patients on the waiting list. In April, as the noble Baroness will of course be aware, NHS England published the new service specification. I am, perhaps, saying this more for the benefit of your Lordships’ House than that of the noble Baroness herself, but I think it is worth reminding ourselves. This requires the services to use the Cass review’s holistic assessment framework and to train clinical staff using a standard professional competence framework designed by the Academy of Medical Royal Colleges. All clinicians working in the NHS Children and Young People’s Gender Service must follow the service specification.
I turn now to Amendment 75, moved by the noble Baroness, Lady Davies. May I say, as she did refer to it, how sorry I am, as I am sure the whole House is, to hear of the circumstances of the death of her mother, about which she spoke before the break. I can tell the noble Baroness that the national review of adult gender services, chaired by Dr David Levy, was published in December last year. It marks a significant step forward in our commitment to improving gender dysphoria services across the NHS.
The noble Lord, Lord Scriven, asked about accountability. As we have discussed in earlier groups, Ministers—in particular, the Secretary of State—are accountable to Parliament, including for these services. The point about the commissioning of these services is of interest to my noble friend Lord Hunt as well. Again, as I confirmed in an earlier group, we anticipate being able to share the list of specialised nationally commissioned services before Report. We are not expecting a great change from what we currently have.
We have publicly committed to implementing the findings and recommendations of the review chaired by Dr David Levy, and the Department of Health and Social Care is working in full partnership with NHS England, which will include the publication of an updated national service specification, as I have mentioned, for adult gender services.
If I had to emphasise one point, it would be that the abolition of NHS England will not impact the work to improve adult gender services. We have made public commitments on the implementations of reviews and recommendations, and that will not change. Effective governance is indeed in place.
The noble Baroness, Lady Davies, referred to the WellBN GP practice. Again, I put on the record that when I talk about the “care” provided by that GP practice, I mean that it was totally unacceptable, and we are working to ensure that those affected are properly supported. I say to all noble Lords that for children and young people with gender dysphoria, and for their safety and well-being, any action taken will always be led by clinical evidence.
On Amendment 275, also in the name of the noble Baroness, Lady Davies, good progress has already been made towards delivering the data linkage study that is referenced in the amendment and was recommended by the noble Baroness, Lady Cass, in her review. On 20 March, an order made by the Secretary of State under Section 22 of the Gender Recognition Act 2004 came into force. That order facilitates lawful data sharing as part of the study, and I am pleased that the Health Research Authority has now improved the study. NHS England has undertaken further positive engagement with data-sharing partners and expects all commissioned adult gender services to collaborate, which is a different situation from what has existed. NHS England will also publish patient information materials shortly, marking the formal launch of the study. Study findings, reported on an aggregated and anonymised basis, will be published once the analysis is complete, and the study forms part of a wider programme of research, again as recommended in the Cass review. As is the case for all publicly funded research, all studies will adhere to ethical data and legal requirements.
On Amendment 276 in the name of the noble Baroness, Lady Davies, the independent Cass review and the NHS review of adult gender services recommended that NHS England should ensure that there is provision for people who are considering detransition. NHS England is acting on those recommendations by developing a clinical pathway for detransition services, and the department will support this work after abolition. It is therefore our view that the amendment is not necessary.
I remind your Lordships’ House that there is very limited evidence to inform this work. NHS England held a call for evidence last year, and a description of a proposed clinical pathway and detransition service will be shared for stakeholder engagement as soon as it is possible to do so in advance of a public consultation. That is likely to include proposals for improving the evidence base through data collection, research activities and clinical audit.
Lastly, on Amendment 279QQ in the name of the noble Baroness, Lady Cash, Section 62 of the Medicines Act 1968 allows the Secretary of State to restrict the sale and supply of medicines where it is necessary to protect patients’ safety. It is a significant order that has been used sparingly. Except in an emergency, that law requires consultation with relevant parties and advice from the independent expert body before restrictions are introduced. Those safeguards are to protect patients and to inform the decision of the Secretary of State. The amendment would require the Secretary of State to introduce restrictions for particular drugs used for a particular purpose, and it would remove the opportunity to consult independent expert advice before deciding whether those restrictions were needed. I therefore hope the noble Baroness will understand our reservations about the amendment.